CharlotteCunningham-RundlesMDPhD
Allergy & Immunology • New York, NYClinical & Laboratory Immunology
David S Gottesman Professor of Medicine, Mount Sinai School of Medicine
Dr. Cunningham-Rundles is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5 E 98th St
New York, NY 10029Phone+1 212-658-9268Fax+1 212-534-0971
Summary
- Charlotte Cunningham-Rundles, MD, is an immunologist based in New York, NY. She completed her medical education at Columbia University and NYU, followed by a PhD in Immunology from NYU. She has served as a professor at the Clinical Immunology Division in the Department of Medicine, and the Department of Pediatrics at Mount Sinai since 1986. Her expertise lies in primary immunodeficiency and antibody production defects, and she has contributed numerous publications on these topics. Cunningham-Rundles has participated in clinical trials on various formulations of intravenous immune globulins, and a study on interleukin 2 for T cell defects in common variable immunodeficiency. She has been recognized with Fellow status from the Clinical Immunology Society and various accolades, including "Top Doctors" listings from Castle Connolly for two decades.
Education & Training
New York UniversityPhD, Immunology , 1971 - 1974
NYU Grossman School of MedicineResidency, Internal Medicine, 1969 - 1972
Columbia University Vagelos College of Physicians and SurgeonsClass of 1969
Certifications & Licensure
FL State Medical License 2020 - Present
NY State Medical License 1971 - 2027
American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Fellow Clinical Immunology Society, 2022
- New York Magazine: Top Doctors Castle Connolly, 2002-2022
- America's Top Doctors Castle Connolly, 2002-2022
- Join now to see all
Clinical Trials
- Randomized Study of Polyethylene-Glycol-Conjugated Interleukin 2 in Patients With Common Variable Immunodeficiency Start of enrollment: 1997 Sep 01
Publications & Presentations
PubMed
- Gut IgA functionally interacts with systemic IgG to enhance antipneumococcal vaccine responses.Cindy Gutzeit, Emilie K Grasset, Dean B Matthews, Paul J Maglione, Graham J Britton
Science Advances. 2025-02-14 - Primary versus Secondary Immune Thrombocytopenia (ITP): A Meeting Report from the 2023 McMaster ITP Summit.Dimpy Modi, Saifur R Chowdhury, Syed Mahamad, Hayley Modi, Douglas B Cines
Thrombosis and Haemostasis. 2025-01-20 - Clinical characterization of NOD2 variants in patients with common variable immunodeficiency.Ashley Sang Eun Lee, Jin Feng, Alp Kazancioglu, Charlotte Cunningham-Rundles
Clinical Immunology. 2025-01-01
Lectures
- Primary Immunodefiencies for the Hematologist: Finding the Needle in the Haystack61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Other
- Clinical manifestations, epidemiology, and diagnosis of common variable immunodeficiency in adultsCunningham-Rundles C, Mayer L, Ahn S
http://www.uptodate.com/contents/clinical-manifestations-epidemiology-and-diagnosis-of-common-variab
UpToDate, Wolters Kluwer Health - 2012-10-09 - Pathogenesis of common variable immunodeficiencyCunningham-Rundles C, Mayer L, Ahn S
http://www.uptodate.com/contents/pathogenesis-of-common-variable-immunodeficiency
UpToDate, Wolters Kluwer Health - 2012-08-21 - Treatment and prognosis of common variable immunodeficiencyCunningham-Rundles C, Mayer L, Ahn S
http://www.uptodate.com/contents/treatment-and-prognosis-of-common-variable-immunodeficiency
UpToDate, Wolters Kluwer Health - 2012-10-26
Press Mentions
Here’s Why Poisonous Animals Don’t Poison ThemselvesAugust 5th, 2021- People Who Already Had COVID-19 Should Still Get Vaccinated, Scientists UrgeAugust 4th, 2021
Gene Therapy Might Prove a Cure for 'Bubble Boy' DiseaseApril 19th, 2019- Join now to see all
Grant Support
- 2nd North American Meeting By CIS Devoted To Primary Immune Deficiency.National Institute Of Allergy And Infectious Diseases2012
- Resources To Assist Investigations In Primary Immunodeficiency Diseases (U24)National Institute Of Allergy And Infectious Diseases2010–2012
- Patient Care CoreNational Institute Of Allergy And Infectious Diseases2011
- Investigating Blocks To B Cell Memory In CVIDNational Institute Of Allergy And Infectious Diseases2011
- Administrative CoreNational Institute Of Allergy And Infectious Diseases2011
- Cellular &Molecular Defects In Human B Cell DevelopmentNational Institute Of Allergy And Infectious Diseases2010–2011
- CIS First North American Primary Immune Deficiency National ConferenceNational Institute Of Allergy And Infectious Diseases2010
- Primary Immunodeficiency Diseases Consortium ConferenceNational Institute Of Allergy And Infectious Diseases2009
- Cellular &Molecular Defects In Human B Cell DevelopmentNational Institute Of Allergy And Infectious Diseases2009
- Targeting Primary Immunodeficiency Among MinoritiesNational Institute Of Allergy And Infectious Diseases2000–2009
- Primary Immune Deficiency Consortium ConferenceNational Institute Of Allergy And Infectious Diseases2006–2008
- Investigating Blocks To B Cell Memory In CVIDNational Institute Of Allergy And Infectious Diseases2004–2008
- Core--Patient AcquisitionNational Institute Of Allergy And Infectious Diseases2004–2008
- Cellular/ Molecular Defects In Human B Cell DevelopmentNational Institute Of Allergy And Infectious Diseases2004–2008
- Primary Immunne Deficiency Consortium ConferenceNational Institute Of Allergy And Infectious Diseases2005
- 2003 CIS Summer SchoolNational Institute Of Environmental Health Sciences2003
- 2002 Summer School In Primary Immunodeficiency DisordersNational Institute Of Allergy And Infectious Diseases2002
- Mechanisms Of IL-2 Immune Enhancement In HumansNational Institute Of Allergy And Infectious Diseases1999–2001
- International Symposium On Clinical Immunology, 1995National Institute Of Allergy And Infectious Diseases1995
- Effects Of Peg-Il-2 In Primary Immunodeficiency DiseaseNational Cancer Institute1990–1991
- Cross Reactive Idiotypes In Human SERANational Institute Of Allergy And Infectious Diseases1986–1988
Professional Memberships
- Fellow
- Clinical Immunology SocietyFellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
